133 related articles for article (PubMed ID: 21460604)
1. Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myeloma.
El Cheikh J; Kfoury E; Calmels B; Lemarie C; Stoppa AM; Bouabdallah R; Coso D; Schiano De Collela JM; Ladaique P; Gastaut JA; Mohty M; Chabannon C; Blaise D
Hematol Oncol Stem Cell Ther; 2011; 4(1):30-6. PubMed ID: 21460604
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the feasibility and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma.
Muta T; Miyamoto T; Fujisaki T; Ohno Y; Kamimura T; Kato K; Takenaka K; Iwasaki H; Eto T; Takamatsu Y; Teshima T; Akashi K;
Intern Med; 2013; 52(1):63-70. PubMed ID: 23291675
[TBL] [Abstract][Full Text] [Related]
3. Treatment of multiple myeloma.
San Miguel JF; Bladé Creixenti J; García-Sanz R
Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma.
El-Cheikh J; Crocchiolo R; Furst S; Stoppa AM; Ladaique P; Faucher C; Calmels B; Lemarie C; De Colella JM; Granata A; Coso D; Bouabdallah R; Chabannon C; Blaise D
Am J Hematol; 2013 May; 88(5):370-4. PubMed ID: 23460414
[TBL] [Abstract][Full Text] [Related]
5. Autologous stem cell transplant for multiple myeloma patients 70 years or older.
Muchtar E; Dingli D; Kumar S; Buadi FK; Dispenzieri A; Hayman SR; Wolf RC; Gastineau DA; Chakraborty R; Hogan WJ; Leung N; Kapoor P; Lacy MQ; Rajkumar SV; Gertz MA
Bone Marrow Transplant; 2016 Nov; 51(11):1449-1455. PubMed ID: 27376447
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial.
van de Donk NW; van der Holt B; Minnema MC; Vellenga E; Croockewit S; Kersten MJ; von dem Borne PA; Ypma P; Schaafsma R; de Weerdt O; Klein SK; Delforge M; Levin MD; Bos GM; Jie KG; Sinnige H; Coenen JL; de Waal EG; Zweegman S; Sonneveld P; Lokhorst HM
Lancet Haematol; 2018 Oct; 5(10):e479-e492. PubMed ID: 30290905
[TBL] [Abstract][Full Text] [Related]
7. Results of autologous stem cell transplant in multiple myeloma patients with renal failure.
Badros A; Barlogie B; Siegel E; Roberts J; Langmaid C; Zangari M; Desikan R; Shaver MJ; Fassas A; McConnell S; Muwalla F; Barri Y; Anaissie E; Munshi N; Tricot G
Br J Haematol; 2001 Sep; 114(4):822-9. PubMed ID: 11564069
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
[TBL] [Abstract][Full Text] [Related]
9. Survival of multiple myeloma patients aged 65-70 years in the era of novel agents and autologous stem cell transplantation. A multicenter retrospective collaborative study of the Japanese Society of Myeloma and the European Myeloma Network.
Ozaki S; Harada T; Saitoh T; Shimazaki C; Itagaki M; Asaoku H; Kuroda Y; Chou T; Yoshiki Y; Suzuki K; Murakami H; Hayashi K; Mina R; Palumbo A; Shimizu K; ;
Acta Haematol; 2014; 132(2):211-9. PubMed ID: 24662986
[TBL] [Abstract][Full Text] [Related]
10. Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma.
Olin RL; Vogl DT; Porter DL; Luger SM; Schuster SJ; Tsai DE; Siegel DL; Cook RJ; Mangan PA; Cunningham K; Stadtmauer EA
Bone Marrow Transplant; 2009 Mar; 43(5):417-22. PubMed ID: 18850013
[TBL] [Abstract][Full Text] [Related]
11. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
Terpos E; Apperley JF; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman JM; Rahemtulla A
Bone Marrow Transplant; 2003 Feb; 31(3):163-70. PubMed ID: 12621476
[TBL] [Abstract][Full Text] [Related]
12. Survival of myeloma patients following the introduction of thalidomide as a second-line therapy: a retrospective study at a single New Zealand centre.
Fernyhough LJ; Hock BD; Taylor J; Pearson J; Ganly P
Intern Med J; 2013 Feb; 43(2):130-7. PubMed ID: 22530659
[TBL] [Abstract][Full Text] [Related]
13. Impact of early relapse after auto-SCT for multiple myeloma.
Kumar S; Mahmood ST; Lacy MQ; Dispenzieri A; Hayman SR; Buadi FK; Dingli D; Rajkumar SV; Litzow MR; Gertz MA
Bone Marrow Transplant; 2008 Sep; 42(6):413-20. PubMed ID: 18587435
[TBL] [Abstract][Full Text] [Related]
14. The role of autologous transplantation in patients with multiple myeloma aged 65 years and over.
Sirohi B; Powles R; Treleaven J; Mainwaring P; Kulkarni S; Pandha H; Bhagwati N; Horton C; Singhal S; Mehta J
Bone Marrow Transplant; 2000 Mar; 25(5):533-9. PubMed ID: 10713631
[TBL] [Abstract][Full Text] [Related]
15. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo.
Majolino I; Vignetti M; Meloni G; Vegna ML; Scimè R; Tringali S; Amaddii G; Coser P; Tribalto M; Raimondi R; Bergonzi C; Sajeva MR; Sica S; Ferrando F; Messina G; Mandelli F
Haematologica; 1999 Sep; 84(9):844-52. PubMed ID: 10477460
[TBL] [Abstract][Full Text] [Related]
16. Real-life data on safety and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma.
Marini C; Maia T; Bergantim R; Pires J; Aguiar E; Guimarães JE; Trigo F
Ann Hematol; 2019 Feb; 98(2):369-379. PubMed ID: 30368589
[TBL] [Abstract][Full Text] [Related]
17. Survival analysis of patients with Hodgkin lymphoma who failed high dose chemotherapy and autologous stem cell transplant.
Elshenawy MA; Shahzad Rauf M; Elhassan TAM; Maghfoor I; Akhtar S
Ann Hematol; 2018 Jul; 97(7):1229-1240. PubMed ID: 29484455
[TBL] [Abstract][Full Text] [Related]
18. Autologous stem cell transplantation in multiple myeloma patients over 70 years: A GIMEMA Lazio Working Group experience in a retrospective case-control study.
Rago A; Annibali O; Tomarchio V; Coppetelli U; Fazio F; Cupelli L; Fiorini A; Piciocchi A; Tafuri A; Caravita di Toritto T
Eur J Haematol; 2022 Sep; 109(3):250-256. PubMed ID: 35617025
[TBL] [Abstract][Full Text] [Related]
19. Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years.
Badros A; Barlogie B; Siegel E; Morris C; Desikan R; Zangari M; Fassas A; Anaissie E; Munshi N; Tricot G
Br J Haematol; 2001 Sep; 114(3):600-7. PubMed ID: 11552985
[TBL] [Abstract][Full Text] [Related]
20. Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation.
Cordas Dos Santos DM; Saliba RM; Patel R; Bashir Q; Saini N; Hosing C; Kebriaei P; Khouri IF; Nieto Y; Popat U; Ahmed H; Lee HC; Manasanch EE; Patel KK; Thomas SK; Weber DM; Orlowski RZ; Champlin RE; Qazilbash MH
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1077-1083. PubMed ID: 31786242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
